Current Approaches for the Management and Treatment of Uveal Melanoma - Episode 6
Marlana M. Orloff, MD, offers advice for patients who are diagnosed with metastatic uveal melanoma.
Transcript:
What advice do you have for patients and caregivers of those recently diagnosed with uveal melanoma?
Marlana M. Orloff, M.D.: Because metastatic uveal melanoma is so rare, it’s very important that patients seek a provider who’s familiar with the treatment landscape.One of the other things patients with uveal melanoma can do when they’re first diagnosed is seek out information provided by patient advocacy organizations.
Now that Kimmtrak [tebentafusp] has been approved for metastatic uveal melanoma, it has really brought to light a lot of the differences between uveal melanoma and skin melanoma, and the need for additional treatments. Specifically, there’s a huge unmet need that remains for patients who are HLA-A*02:01 negative. I’m happy to say that there are a number of ongoing clinical trials looking at new treatment options. Having an FDA-approved therapy has also brought greater awareness to this rare melanoma subtype.
Thank you for joining me to learn about uveal melanoma. We hope you found this Educated Patient Sound Bites program to be informative.
Transcript edited for clarity.